The Payday Protocol

But early investors could reap a windfall... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Dear Reader, There’s one angle a lot of people are missing with the rise of AI… We are witnessing perhaps the single greatest global transformative event in human history. IBM’s Watson Health AI collaborated with the University of Toronto to create the first new treatment in forty years for a deadly brain tumor in children. The Breakthrough Starshot Project is projecting to send AI-powered spacecrafts to the Alpha Centauri star system – gathering data on collision avoidance and the interstellar void while traveling at 20% of the speed of light. But these great technological ambitions have a cost… And that cost is creating unprecedented strain on outdated systems in North America. However, it has also set the stage for the most lucrative investment opportunity of the decade… When I highlight the 3 critical steps to take today… I’ll lay it all out in detail. But for now, it’s important you understand what this situation is… and why it has put the entire AI revolution in jeopardy… Why it has spurred Billionaires such as Elon Musk, Bill Gates, and Peter Thiel to take immediate action. And why failing to act could leave 300 million men and women across North America living in a new dark age. Let me give you a glimpse… Regards, Marin Katusa Chairman, Katusa Research Copyright © 2024, Katusa Research, All rights reserved. PLEASE READ: RETURNS AND TESTIMONIAL DISCLOSURE  Contact Us | Privacy | Terms & Conditions Details and Disclosures Investing can have large potential rewards, but it can also have large potential risks. You must be aware of the risks and be willing to accept them in order to invest in financial instruments, including stocks, options, and futures. Katusa Research makes every best effort in adhering to publishing exemptions and securities laws. By reading this, you agree to all of the following: You understand this to be an expression of opinions and NOT professional advice. You are solely responsible for the use of any content and hold Katusa Research, and all partners, members, and affiliates harmless in any event or claim. If you purchase anything through a link in this email, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything.

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
Katusa Research, Suite 530 - 800 West Pender St, Vancouver, BC V6C2V6, Canada